Minneapolis, Minnesota-based Zipnosis, which offers whitelabeled telemedicine tools to providers, quietly raised a $3 million funding round last week. The raise came from existing investors. The company’s last round, in January 2016, was supported by Safeguard Scientifics, Ascension Ventures, Fairview Health Services, Hyde Park Venture Partners, Arthur Ventures, Waterline Ventures and Omphalos Ventures. This brings the company’s total funding to $23 million.
“As an organization focused on sustainable, organic growth, we were very intentional about the size of our Series B,” Zipnosis CEO Jon Pearce said in a statement. “In this industry, you hear about huge amounts of cash being splashed around. Zipnosis didn’t require a massive infusion of investment to achieve our growth objectives. It was more important for us to take precisely what we needed to move to the next level – no more and no less.”
In the lead up to HIMSS18, Pearce spoke to MobiHealthNews about his company’s strategy. Whereas many large telemedicine companies are offering services via health insurers or direct to consumer, Zipnosis continues to focus on enabling providers to launch their own telemedicine services.